China
China's Finance Ministry says fined 19 Pharmaceutical companies for inflating drug prices
Beijing/Sputnik: The Chinese Ministry of Finance has fined 19 pharmaceutical companies for violating the country's accounting law and artificially inflating prices for medicines, according to the ministry's website.
The ministry and the National Healthcare Security Administration launched an inspection of accounting information of 77 pharmaceutical companies in 2019 in response to the long-reported problem of high drug prices.
As a result of the ministry's inspections, "administrative sanctions were imposed on 19 pharmaceutical companies," with each of them being fined for 30,000 yuan ($4,500) to 50,000 yuan — the maximum possible fine for such offenses.
The inspection focused on analyzing the cost composition of the companies' products and found a number of major problems in the accounting records of some pharmaceutical companies, including the use of false checks and invoices, as well as incorrect accounting.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
